Posts

Intensive Care Unit Equipment Market to Reach USD 9.03 Billion by 2027; Surge in Cancer Patients to Amplify Business Deals, states Fortune Business Insights™

  The global “ intensive care unit ” equipment market size is predicted to reach USD 9.03 billion by 2027, exhibiting a CAGR of 4.8% during the forecast period. The emergence of novel viruses such as coronavirus will spur demand for life support, patient monitoring, and emergency resuscitation devices, which in turn, will boost the market growth during the forecast period, states Fortune Business Insights in a report, titled “Intensive Care Unit Equipment Market Size, Share and Industry Analysis By Product (Beds, Ventilators, Pulse Oximeters, Dialysis Equipment, and Others), By Patient (Adult and Pediatric), By Application (Neurology, Cardiology, Respiratory, Renal, Oncology, Trauma, and Others), By End-User (Hospitals, Specialty Clinics, and Others and Regional Forecast, 2020-2027” the market size stood at USD 6.16 billion in 2019. Request a Sample Copy of the Research Report Market Driver : Surge in Chronic Diseases to Augment Growth The growing cases of cancer, neurologic disorders,
Post a Comment
Read more

Rheumatoid Arthritis Therapeutics Market valued at US$ 33,958.4 Mn, Introducing Cost-efficient Drugs Will Boost Market, says Fortune Business Insights

  Exhibiting a high prevalence for rheumatoid arthritis, North America is forecast to lead the global “ rheumatoid arthritis therapeutics market ” in a recent report. In a report, titled “RHEUMATOID ARTHRITIS THERAPEUTICS: GLOBAL MARKET ANALYSIS, INSIGHTS AND FORECAST, 2018-2025”, Fortune Business Insights identifies numerous factors enabling growth in the market. According to the report, the global rheumatoid arthritis therapeutics market is anticipated to exhibit 4.6% CAGR and reach valuation of US$ 33,958.4 Mn in 2025 from US$ 23,822.5 Mn in 2017. Request a Sample Copy of the Research Report North America to Lead Global Market with Rising Prevalence of Rheumatoid Arthritis The North America market was worth US$ 9,929.6 Mn in 2017. It is expected to show steady rise owing to the rising prevalence of rheumatoid arthritis and increasing awareness about this disorder. Adding to that, governments of North America are investing huge sums for improving the healthcare and medical facilities
Post a Comment
Read more

Netherlands Home Healthcare Market Takes Home US$ 570.0 Mn, Kimberly Clark, Unicharm, and SCA Cover More Than 50% of the Market Share: Fortune Business Insights

  The increasing prevalence of chronic diseases among the geriatric population is driving the “ Netherlands home healthcare market ”. The above information is published in a report, titled “Netherlands Home Healthcare: Market Analysis, Insights and Forecast, 2019-2026.” Fortune Business Insights in the report predicts that rising geriatric population in the Netherlands is leading to high demand for home healthcare equipment. A study by Central Bureau Statistics (CBU), it is estimated that around 3.31 million people in the Netherlands are aged above 65 years. Also, the study predicts that the number will increase by 2026. This further indicates that the adoption of home healthcare products will increase in the forthcoming years. As per the report by Fortune Business Insights, the Netherlands market was worth US$ 570.0 Mn in 2018 and is anticipated to reach US$ 1013.1 Mn by 2026. As home healthcare is a viable option and increasingly adopted by the elderly population, the market for home
Post a Comment
Read more

Global Hepatitis C Drugs Market to Reach US$ 7,351.7 Mn; Increasing Demand for Hepatitis C Drugs Will Favor Growth, says Fortune Business Insights

  The global “ hepatitis C drugs market ” will derive growth impetus from the high prevalence of hepatitis C across the world. According to a report published by Fortune Business Insights, titled “Hepatitis C Drugs: Global Market Analysis, Insights and Forecast, 2019-2026,” the market was valued at US$ 7,866.6 Mn in 2018. Fortune Business Insights states that the market is projected to reach US$ 7,351.7 Mn by 2026, exhibiting a CAGR of -0.9% in the forecast period. Hepatitis C requires oral injections and dosages on a weekly basis, and it also has several side effects that can also lead to permanent damage. Increasing clinical trials and successful drug clearances have aided the overall growth of the global hepatitis C market. Increasing number of regulatory approvals will boost the global hepatitis C market in the forthcoming years. Hepatitis C is a viral infection that causes severe damage such as inflammation of the liver and can spread through contaminated blood. The advanced stage
Post a Comment
Read more

Leukemia Therapeutics Market Worth $27.78 Billion at 8.1% CAGR; Industry Leaders Such as Pfizer and Bristol-Myers to Focus Investments on Advancing Clinical Trials: Fortune Business Insights™

  The global “ leukemia therapeutics market ” size is projected to reach USD 27.78 billion by 2027, exhibiting a CAGR of   8.1%  during the forecast period. The increasing demand for enhanced treatments for blood cancers amid the COVID-19 pandemic will accelerate the market, states Fortune Business Insights™ in its report, titled “Leukemia Therapeutics Market Size, Share & COVID-19 Impact Analysis, By Type of Leukemia (Chronic Myeloid Leukemia (CML), Chronic Lymphocytic Leukemia (CLL), Acute Lymphocytic Leukemia (ALL), Acute Myeloid Leukemia (AML), and Others), By Treatment Type (Chemotherapy, Targeted Therapy, Immunotherapy, and Others), By Route of Administration (Oral Mode and Injectable Mode), By Distribution Channels (Hospital Pharmacy, Retail Pharmacy, and Others), and Regional Forecast, 2020-2027”. Cancer patients are at a heightened risk of contracting the coronavirus and likely to experience severe effects of the infection due to their weakened immune systems. According to
Post a Comment
Read more

Non-steroidal Anti-Inflammatory Drugs Market to Exhibit 5.8%CAGR till the End of 2027; Government Initiatives to Lower Cost Burden Will Favor Growth, says Fortune Business Insights™

  The global “ non-steroidal anti-inflammatory drugs ” market is set to gain momentum from the ever-increasing research activities by several prominent pharmaceutical companies on selective cyclooxygenase-2 inhibitors as they are still a grey area for these companies. Tough, Non-steroidal Anti-Inflammatory Drugs such as ibuprofen and diclofenac are nowadays used to hinder the activity of COX, but they have undesirable effect. Fortune Business Insights™ published this information in a new report, titled, “Non-steroidal Anti-Inflammatory Drugs (Non-steroidal Anti-Inflammatory Drugs) Market Size, Share & Industry Analysis, By Disease Indication (Arthritis, Migraine, Ophthalmic Diseases, and Others), By Route of Administration (Oral, and Parenteral), By Distribution Channel (Hospital Pharmacy Retail Pharmacy, and Online Pharmacy), and Regional Forecast, 2020-2027.” The report further mentions that the Non-Steroidal Anti-Inflammatory Drugs market size was USD 15.58 billion in 2019 and i
Post a Comment
Read more

Lymphoma Treatment Market | 2021 Size, Share, Sales, Demand, Growth, Merger, Trends, Competitive Landscape And Regional Outlook To 2026, says Fortune Business Insights

  Global   Lymphoma Treatment Market   | 2021 Global Healthcare Industry Analysis To 2028, is latest report on Global Lymphoma Treatment Industry, published by Fortune Business Insights. According to this report Global Lymphoma Treatment Market to rise at healthy Compound Annual Growth Rate by 2028. Market for Lymphoma Treatment Industry is segmented By Product Type (Lymphoma Treatment Frames and Spectacle Lenses), By Modality (Prescription and Over-the-counter) By Distribution Channel (Retail Store, Online Store, Ophthalmic Clinics), and Regional Forecast, 2019-2026 Major Lymphoma Treatment Manufacturers covered in the market report include: Takeda Pharmaceutical Company Limited AstraZeneca Bayer AG Novartis AG Kite Pharma, Inc. / Gilead Sciences, Inc. Spectrum Pharmaceuticals, Inc. Teva Pharmaceutical Industries Ltd. Bristol Myers Squibb Company Janssen Pharmaceuticals, Inc. Get Sample PDF Brochure of Lymphoma Treatment Market Report at: https://www.fortunebusinessinsights.com/enquir
Post a Comment
Read more